Crowded names
One fund taking a stake is a signal. Several unrelated funds sitting on the register in the same name at the same time is a louder one. This board counts, for every name across Japan, the UK, Korea, Europe and the US, how many of the tracked funds currently hold a live disclosed position, and ranks the names by how many funds are circling (2+ to appear; 0 US and 5 international names today).
A position counts only while it is verifiably live. In the disclosure markets that means the fund’s latest large-shareholding filing still shows the stake above the reporting threshold (5% in Japan and Korea, 3% in the UK and Europe); an exit or below-threshold filing removes it. In the US it means the name sits at 3%+ of the fund’s most recent 13F book, a conviction-size holding, so index-like residue never inflates the count. Disclosed positions, not model predictions, see how it works. Research, not advice.
| # | Name | Market | Funds | Who is in | Combined | Latest filing |
|---|---|---|---|---|---|---|
| 1 | DSM-Firmenich AG | Europe (NL) | 38 | eu_c_a_firmenich 22.1% · eu_summit_trust_cayman_limited 22.1% · eu_l_c_firmenich 22.1% · eu_x_r_bardy 22.1% · eu_j_f_firmenich 22.1%+33 moreeu_p_g_firmenich 22.1% · eu_l_firmenich 22.1% · eu_f_guntern_burrus 22.1% · eu_c_meyer_firmenich 22.1% · eu_f_burrus 22.1% · eu_f_a_firmenich 22.1% · eu_n_a_firmenich 22.1% · eu_c_michaud_meyer 22.1% · eu_a_bardy_firmenich 22.1% · eu_a_a_firmenich 22.1% · eu_d_oltramare 22.1% · eu_i_boer_bardy 22.1% · eu_n_c_firmenich 22.1% · eu_g_bardy 22.1% · eu_d_firmenich 22.1% · eu_a_v_firmenich 22.1% · eu_m_a_firmenich 22.1% · eu_o_canevet 22.1% · eu_a_schofield_burrus 22.1% · eu_p_firmenich 22.1% · eu_s_j_firmenich 22.1% · eu_s_genecand 22.1% · eu_s_firmenich 22.1% · eu_c_r_firmenich 22.1% · eu_m_jaeger_firmenich 22.1% · eu_m_m_firmenich 22.1% · eu_ubs_group_ag 5.5% · eu_artisan_investments_gp_llc 5.0% · eu_blackrock_inc 4.6% · eu_bank_of_america_corporation 3.7% · eu_a_pometta 3.0% · eu_m_keller_pometta 3.0% · eu_s_pometta 3.0% | 712.9% of company | 2026-06-24 |
| 2 | AMG Critical Materials N.V. | Europe (NL) | 27 | eu_stichting_continuiteit_amg 236.3% · eu_van_eck_associates_corporation 9.9% · eu_soci_t_g_n_rale_s_a 5.9% · eu_brightsphere_inc 5.8% · eu_old_mutual_limited 5.3%+22 moreeu_oppenheimerfunds_inc 5.1% · eu_t_rowe_price_group_inc 4.9% · eu_delta_lloyd_deelnemingen_fonds_n_v 4.9% · eu_fidelity_fund_sicav 4.9% · eu_american_funds_insurance_series_global_growth_fu 4.9% · eu_fmr_llc 4.7% · eu_c_leone 4.7% · eu_ubs_ag 4.6% · eu_citadel_equity_fund_limited 4.6% · eu_citadel_investment_group_europe_limited 4.6% · eu_pantheon_ventures_uk_llp 4.5% · eu_hunter_hall_investment_management_limited 4.5% · eu_capital_research_and_management_company 4.4% · eu_smallcap_world_fund_inc 4.4% · eu_jp_morgan_chase_co 4.3% · eu_dws_investment_gmbh 4.3% · eu_sculptor_capital_lp 4.0% · eu_blackrock_inc 3.7% · eu_goldman_sachs_group_inc_the 3.6% · eu_h_schimmelbusch 3.0% · eu_bnp_paribas_asset_management_holding 3.0% · eu_marble_bar_asset_management_llp 3.0% | 358.1% of company | 2026-06-12 |
| 3 | Alebund Pharmaceuticals (Jiangsu) Ltd. - B - H Shares09637 | HK | 23 | yangzhou_liyue_consulting_management_partnership_limited_partnership 11.8% · aleyuanjt_limited 11.8% · shanghai_chunyuan_pharmaceutical_technology_partnership_limited_partnership 11.8% · aleyuan_limited 11.8% · aleyuan_inc 11.8%+18 morealeyuangx_limited 11.8% · oriental_power_holdings_limited 11.8% · tencent_holdings 10.0% · shanghai_yuanyue_consulting_management_partnership_limited_partnership 8.7% · tencent_technology_shenzhen_company_limited 8.2% · guangxi_tencent_venture_capital_co_ltd 8.2% · shenzhen_tencent_ruijian_investment_co_ltd 8.2% · shenzhen_tencent_ruitou_enterprise_management_co_ltd 7.9% · shenzhen_tenglv_enterprise_management_partnership_limited_partnership 7.9% · shenzhen_tengqing_enterprise_management_co_ltd 7.9% · shenzhen_tengyuan_enterprise_management_partnership_limited_partnership 7.9% · lav_asset_management_hong_kong_limited 7.0% · gic_private_limited 6.8% · quan_venture_partners 6.7% · lav_biosciences_fund_iv_l_p 6.4% · lav_gp_iv_l_p 6.4% · lav_corporate_iv_gp_ltd 6.4% · lav_delta_limited 6.4% | 203.7% of company | 2026-08-20 |
| 4 | SENASIC Electronics Technology Co., Ltd. - H Shares06675 | HK | 21 | schroder_asian_opportunities 100.0% · shanghai_yaojun_management_consulting_co_ltd 15.1% · shanghai_yingzhixin_enterprise_management_partnership_limited_partnership 7.8% · shanghai_chuangyingrui_enterprise_management_partnership_limited_partnership 7.8% · shanghai_ruizhichuang_enterprise_management_partnership_limited_partnership 7.8%+16 moreshanghai_ruixinchuang_enterprise_management_partnership_limited_partnership 6.5% · shanghai_ruizhixin_enterprise_management_partnership_limited_partnership 6.5% · shanghai_ruizhiying_enterprise_management_partnership_limited_partnership 6.5% · sk_china_company_limited 5.5% · hai_feng_investment_holding_limited 5.5% · union_season_holdings_limited 5.5% · sk_inc 5.5% · sk_innovation_co_ltd 5.5% · sk_investment_management_co_ltd 5.5% · sk_semiconductor_investments_co_ltd 5.5% · sl_capital_fund_i_l_p 5.5% · sl_capital_partners_limited 5.5% · slsf_i_gp_limited 5.5% · hangzhou_jingwei_investment_management_co_ltd 5.2% · hangzhou_chuangqian_investment_partnership_limited_partnership 5.2% · hangzhou_maiqisi_investment_partnership_limited_partnership 5.2% | 229.0% of company | 2026-06-22 |
| 5 | IMPACT Therapeutics, Inc - B - H Shares07630 | HK | 21 | lav_asset_management_hong_kong_limited 14.0% · shanghai_liyao_investment_management_co_ltd 11.8% · decheng_capital_china_life_sciences_usd_fund_iii_l_p 8.5% · decheng_impact_limited 8.5% · decheng_capital_management_iii_cayman_llc 8.5%+16 moretencent_holdings 7.0% · shanghai_li_yi_investment_management_partnership_limited_partnership 6.0% · oriental_power_holdings_limited 5.9% · shenzhen_tengyuan_enterprise_management_partnership_limited_partnership 5.7% · shenzhen_tencent_ruitou_enterprise_management_co_ltd 5.7% · shenzhen_tencent_ruijian_investment_co_ltd 5.7% · shenzhen_tengqing_enterprise_management_co_ltd 5.7% · shenzhen_tenglv_enterprise_management_partnership_limited_partnership 5.7% · tencent_technology_shenzhen_company_limited 5.7% · guangxi_tencent_venture_capital_co_ltd 5.7% · shanghai_lian_venture_capital_investment_center_limited_partnership 5.3% · shanghai_lihan_biotech_l_p 5.3% · lav_enterprise_hong_kong_limited 5.2% · lav_biosciences_fund_iv_l_p 5.2% · lav_corporate_iv_gp_ltd 5.2% · lav_gp_iv_l_p 5.2% | 141.1% of company | 2026-07-03 |
Names where multiple tracked funds hold a live disclosed position at the same time. Disclosure markets (JP/UK/KR/EU): the fund's latest large-shareholding filing on the name is still above the reporting threshold; combined = sum of their stakes in the company. US: the name is >= 3% of the fund's latest 13F book; combined = sum of their portfolio weights. Disclosed positions, not predictions, and not advice. Percentages mean different things by regime: in the disclosure markets the combined figure is the funds’ summed stake in the company; in the US it is the summed share of each fund’s own portfolio. Rankings use the fund count first so the two scales never compete. A name drops off the moment any counted fund’s newest filing is an exit or falls below the reporting threshold. Sources: EDINET 大量保有報告書 (JP), FCA NSM TR-1 (UK), OpenDART (KR), AFM substantial holdings (EU/NL), SEC 13F (US). As of 2026-09-22. Research, not advice.